Comparison of three PD-L1 immunohistochemical assays in head and neck squamous cell carcinoma (HNSCC)

E.J. de Ruiter, F.J. Mulder, B.M. Koomen, E.J. Speel, M.F.C.M. van den Hout, R.H. de Roest, E. Bloemena, L.A. Devriese, S.M. Willems

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1125-1132
Number of pages8
JournalModern Pathology
Volume34
Issue number6
Early online date5 Aug 2020
DOIs
Publication statusPublished - Jun 2021

Keywords

  • checkmate 141
  • investigators choice
  • nivolumab
  • pembrolizumab
  • recurrent
  • PEMBROLIZUMAB
  • RECURRENT
  • CHECKMATE 141
  • INVESTIGATORS CHOICE
  • NIVOLUMAB

Cite this